MedTrace Logo

Swiss Paediatric Airway Cohort

NCT03505216 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2026-04-21

No results posted yet for this study

Summary

The Swiss Paediatric Airway Cohort (SPAC) is a national, prospective clinical cohort of children and adolescents who visit physicians in Switzerland for recurrent wheeze, cough, and exercise- or sleep-related respiratory problems. SPAC aims to answer important questions on clinical phenotypes, prognosis, diagnosis and treatment. SPAC is part of routine care, and only clinically indicated investigations are done. The comprehensive baseline assessment includes a detailed questionnaire to families, plus test results, diagnoses and treatments from hospital records. Follow-up is via monthly questionnaires the first 12 months and thereafter annual questionnaires to families, and data from follow-up visits.

Currently, 4344 patients from 10 clinics and hospitals in Switzerland (Aarau, Basel, Bern, Chur, Horgen, Lausanne, Luzern, St. Gallen, Worb, Zurich) have been enrolled.

SPAC provides real-life data on children visiting the Swiss health care system for common respiratory problems. It will provide a research platform for health services research, and for nested clinical and transitional studies.

Publications and plain language summaries are listed on the study website: https://www.spac-study.ch/publikationen/

Conditions

  • Asthma
  • Wheezing
  • Cough
  • Exercise Induced Bronchospasm
  • Inspiratory Laryngeal Obstruction
  • Dysfunctional Breathing

Sponsors & Collaborators

  • University of Bern

    lead OTHER

Principal Investigators

  • Claudia E Kuehni, Prof. · Institute of Social and Preventive Medicine

Eligibility

Min Age
0 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-06
Primary Completion
2026-09-01
Completion
2030-06-01

Countries

  • Austria
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03505216 on ClinicalTrials.gov